Similar to that reported in the AML cohort, no correlations with WBCs were described (r = −0.094; p = 0.3634), while negative correlations between normalized WT1 levels and platelets (r = −0.2044; p = 0.0470) and hemoglobin levels (r = −0.3386; p = 0.0008) were confirmed in MDS patients (Figure 3A). This evidence concerns the gene WT1 and acute myeloid leukemia.